Xu J - Search Results

1

Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.

Chen G, Xu C, Gillette TG, Huang T, Huang P, Li Q, Li X, Li Q, Ning Y, Tang R, Huang C, Xiong Y, Tian X, Xu J, Xu J, Chang L, Wei C, Jin C, Hill JA, Yang Y. Chen G, et al. Among authors: xu c, xu j. Theranostics. 2020 Sep 23;10(25):11754-11774. doi: 10.7150/thno.43163. eCollection 2020. Theranostics. 2020. PMID: 33052245 Free PMC article.

2

Quantitative Proteomics Analysis of Ischemia/Reperfusion Injury-Modulated Proteins in Cardiac Microvascular Endothelial Cells and the Protective Role of Tongxinluo.

Li Q, Cui HH, Yang YJ, Li XD, Chen GH, Tian XQ, Jin C, Dong QT, Huang PS, Xu J. Li Q, et al. Among authors: xu j. Cell Physiol Biochem. 2017;41(4):1503-1518. doi: 10.1159/000470806. Epub 2017 Mar 24. Cell Physiol Biochem. 2017. PMID: 28334711 Free article.

3

Exosomes: promising sacks for treating ischemic heart disease?

Chen GH, Xu J, Yang YJ. Chen GH, et al. Among authors: xu j. Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H508-H523. doi: 10.1152/ajpheart.00213.2017. Epub 2017 Jun 23. Am J Physiol Heart Circ Physiol. 2017. PMID: 28646026 Free article. Review.

4

Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.

Chen GH, Xu CS, Zhang J, Li Q, Cui HH, Li XD, Chang LP, Tang RJ, Xu JY, Tian XQ, Huang PS, Xu J, Jin C, Yang YJ. Chen GH, et al. Among authors: xu jy, xu cs, xu j. Front Pharmacol. 2017 Oct 30;8:775. doi: 10.3389/fphar.2017.00775. eCollection 2017. Front Pharmacol. 2017. PMID: 29163161 Free PMC article.

5

Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.

Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Cheng K, Qian L, Yang Y. Huang P, et al. Among authors: xu j. Cardiovasc Res. 2020 Feb 1;116(2):353-367. doi: 10.1093/cvr/cvz139. Cardiovasc Res. 2020. PMID: 31119268 Free PMC article.

6

Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction.

Xu J, Xiong YY, Li Q, Hu MJ, Huang PS, Xu JY, Tian XQ, Jin C, Liu JD, Qian L, Yang YJ. Xu J, et al. Among authors: xu jy. Stem Cells Transl Med. 2019 Oct;8(10):1068-1083. doi: 10.1002/sctm.19-0013. Epub 2019 Jun 27. Stem Cells Transl Med. 2019. PMID: 31245934 Free PMC article.

7

Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis.

Tian XQ, Yang YJ, Li Q, Xu J, Huang PS, Xiong YY, Li XD, Jin C, Qi K, Jiang LP, Chen GH, Qian L, Liu J, Geng YJ. Tian XQ, et al. Among authors: xu j. Am J Transl Res. 2019 Jul 15;11(7):4214-4231. eCollection 2019. Am J Transl Res. 2019. PMID: 31396330 Free PMC article.

8

Transplantation efficacy of autologous bone marrow mesenchymal stem cells combined with atorvastatin for acute myocardial infarction (TEAM-AMI): rationale and design of a randomized, double-blind, placebo-controlled, multi-center, Phase II TEAM-AMI trial.

Xu JY, Qian HY, Huang PS, Xu J, Xiong YY, Jiang WY, Xu Y, Leng WX, Li XD, Chen GH, Tang RJ, Huang CR, Hu MJ, Jin C, Wu Y, Zhang J, Qian J, Xu B, Zhao SH, Lu MJ, Shen R, Fang W, Wu WC, Chen X, Wang Y, Li W, Lu XF, Jiang XF, Ma CC, Li JW, Geng YJ, Qiao SB, Gao RL, Yang YJ. Xu JY, et al. Among authors: xu b, xu y, xu j. Regen Med. 2019 Dec;14(12):1077-1087. doi: 10.2217/rme-2019-0024. Epub 2019 Dec 12. Regen Med. 2019. PMID: 31829095 Clinical Trial.

9

Strengthening effects of bone marrow mononuclear cells with intensive atorvastatin in acute myocardial infarction.

Yang YJ, Qian HY, Song L, Geng YJ, Gao RL, Li N, Wang H, Tian XQ, Huang J, Huang PS, Xu J, Shen R, Lu MJ, Zhao SH, Wu WC, Wu Y, Zhang J, Qian J, Xu JY, Xiong YY. Yang YJ, et al. Among authors: xu jy, xu j. Open Heart. 2020 May;7(1):e001139. doi: 10.1136/openhrt-2019-001139. Open Heart. 2020. PMID: 32393654 Free PMC article. Clinical Trial.

10

Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction.

Xu JY, Xiong YY, Tang RJ, Jiang WY, Ning Y, Gong ZT, Huang PS, Chen GH, Xu J, Wu CX, Hu MJ, Xu J, Xu Y, Huang CR, Jin C, Lu XT, Qian HY, Li XD, Yang YJ. Xu JY, et al. Among authors: xu y, xu j. Cardiovasc Res. 2022 Jul 20;118(9):2165-2178. doi: 10.1093/cvr/cvab237. Cardiovasc Res. 2022. PMID: 34259869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62,017 results

Search Page